XML 25 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
Inventories Inventories- Schedule of Inventories (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Dec. 31, 2012
Inventory Disclosure [Abstract]    
Raw materials $ 4,796 $ 3,754
Work-in-process 2,930 11,317
Finished goods 13,806 15,393
Total $ 21,532 [1] $ 30,464 [1]
[1] Amounts include the assets and liabilities of Vertex’s variable interest entity (“VIE”), Alios BioPharma, Inc. (“Alios”). Vertex’s interests and obligations with respect to the VIE’s assets and liabilities are limited to those accorded to Vertex in its agreement with Alios. See Note C, "Collaborative Arrangements," to these condensed consolidated financial statements for amounts.